Aegon Bank successfully prices inaugural EUR 500 million Senior Non-Preferred notes

 

Aegon Bank successfully prices inaugural EUR 500 million Senior Non-Preferred notes

 

Bristol-Myers Squibb Presents Updated Efficacy Data from Phase 2 Trial of Empliciti (elotuzumab) Plus Pomalidomide and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma (RRMM)

 

bluebird bio Presents Long-Term Efficacy and Safety Data from Clinical Studies of LentiGlobin® Gene Therapy for Transfusion-Dependent β-Thalassemia (TDT) at 24th European Hematology Association (EHA) Congress

 

bluebird bio Presents New Data for LentiGlobin® Gene Therapy for Sickle Cell Disease (SCD) at 24th European Hematology Association (EHA) Congress

 

Velodyne Features Advanced Lidar for Port Terminal Automation at TOC Europe

 

ArQule Announces Clinical Proof-of-Concept Data from Ongoing Phase 1 Study of Reversible BTK Inhibitor, ARQ 531, in Patients with Relapsed/Refractory Hematologic Malignancies at the 2019 EHA Annual Meeting

 

OpenGate Capital Sells Omniplast BV to Consortium of Investors

 

Healthcare: Air Liquide Reinforces Its Presence in Europe with the Acquisition of Medidis in the Netherlands

 

Registration Open for CES Unveiled in Amsterdam and CES Unveiled in Paris